Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP467323.RA3LGzsnd9sysadjy3NGsPwKcINSpljbb3Wd3KkiqGEa4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP467323.RA3LGzsnd9sysadjy3NGsPwKcINSpljbb3Wd3KkiqGEa4130_assertion type Assertion NP467323.RA3LGzsnd9sysadjy3NGsPwKcINSpljbb3Wd3KkiqGEa4130_head.
- NP467323.RA3LGzsnd9sysadjy3NGsPwKcINSpljbb3Wd3KkiqGEa4130_assertion description "[Recent advances in transgenic and gene therapy techniques have presented novel therapeutic strategies for management of heart failure via genetic manipulation of beta-AR signaling including the targeted inhibition of the beta-AR kinase (betaARK1 or GRK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP467323.RA3LGzsnd9sysadjy3NGsPwKcINSpljbb3Wd3KkiqGEa4130_provenance.
- NP467323.RA3LGzsnd9sysadjy3NGsPwKcINSpljbb3Wd3KkiqGEa4130_assertion evidence source_evidence_literature NP467323.RA3LGzsnd9sysadjy3NGsPwKcINSpljbb3Wd3KkiqGEa4130_provenance.
- NP467323.RA3LGzsnd9sysadjy3NGsPwKcINSpljbb3Wd3KkiqGEa4130_assertion SIO_000772 15524162 NP467323.RA3LGzsnd9sysadjy3NGsPwKcINSpljbb3Wd3KkiqGEa4130_provenance.
- NP467323.RA3LGzsnd9sysadjy3NGsPwKcINSpljbb3Wd3KkiqGEa4130_assertion wasDerivedFrom befree-2016 NP467323.RA3LGzsnd9sysadjy3NGsPwKcINSpljbb3Wd3KkiqGEa4130_provenance.
- NP467323.RA3LGzsnd9sysadjy3NGsPwKcINSpljbb3Wd3KkiqGEa4130_assertion wasGeneratedBy ECO_0000203 NP467323.RA3LGzsnd9sysadjy3NGsPwKcINSpljbb3Wd3KkiqGEa4130_provenance.